PREPARATION AND UTILITY OF SUBSTITUTED ERYTHROMYCIN ANALOGS

摘要

The present disclosure is directed to novel macrolide antibiotics of Form ula (I) and pharmaceutically acceptable salts and prodrugs thereof; and the chemical syntheses and medical uses of these novel macrolide antibiotics for the treatment and/or management of infections caused by various aerobic and anaerobic gram-positive and gram-negative microorganisms as well as various mycobacteria.